Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(12):848-849; doi:10.1093/jnci/95.12.848
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by McCann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCann, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 95, No. 12, 848-849, June 18, 2003
© 2003 Oxford University Press

NEWS

Lowering Immune Suppression Drugs Post-Transplant May Cut Cancer Risk

Jean McCann

The first 10% of the full text of this article appears below.

Major advances in surgery and in immunosuppressive drugs have made organ and tissue transplantation a more routine procedure. Nevertheless, the procedures still have risks, including an increased risk of developing cancer, particularly skin cancers and lymphomas. But one approach—actually lowering the dosage and number of immunosuppressive drugs—may spare patients some of the ill effects of long-term immunosuppression.

Thomas Starzl, M.D., Ph.D., of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?